# Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants

> **NCT02367885** · PHASE1,PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 99 (actual)

## Conditions studied

- Influenza Infection

## Interventions

- **DRUG:** TAK-850 0.5 mL injection
- **DRUG:** TAK-850 0.25 mL injection

## Key facts

- **NCT ID:** NCT02367885
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2016-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02367885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02367885, "Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02367885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*